Second, we found positive correlations between CLEC4A expression and the presence of different innate immune cell subtypes in the CRC tumor, which is not surprising at first glance considering that DCIR is mainly expressed by myeloid cells. The gene discussed is CLEC4A; the disease is neoplasm.